Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
Inhibition of DAPK2 (unknown origin) at 10 uM by biochemical hotspot kinase assay relative to control
Assay data:1 Tested
SummaryRelated BioAssays by Target
Inhibition of wild type human DAPK2 in presence of ATP by radiometric kinase assay
Inhibition of wild type human DAPK2 at 1 uM by DiscoverX scanMAX assay relative to control
Selectivity interaction (KinomeScan (DiscoverX)) EUB0000747a DAPK2
Inhibition of DAPK2 (unknown origin) at 1 uM relative to control
SummaryPubMed CitationRelated BioAssays by Target
DAPK2 DiscoveRx kinase panel
DAPK2(h) Kinase panel
Inhibition of DAPK2 (unknown origin) at 1 uM
KinomeScan assay: inhibition of DAPK2
Assay data:108 Tested
DAPK2(DAP2LGF1) Takeda global kinase panel
Assay data:1 Activity ≤ 1 µM, 1 Tested
SummaryCompounds, activity ≤ 1 µMRelated BioAssays by Target
DAPK2(h) Eurofins kinase panel
DAPK2 ProQinase selectivity panel
DAPK2(h) Eurofins Kinase panel
DAPK2 (h) Millipore kinase activity assay
DAPK2(h) Millipore kinase panel
death-associated protein kinase 2 Millipore kinase panel
DAPK2 Invitrogen Lab (UK) kinase screen (BI)
Inhibition of human recombinant full length DAPK2 using Calmodulin as substrate at 100 nM direct filter-binding radiometric kinase activity assay relative to control
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on